F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
28.04
-0.81 (-2.82%)
Sep 12, 2025, 4:00 PM EDT - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 37 individual holdings. The top holdings are LivaNova stock at 6.71%, Travere Therapeutics at 6.22%, Soleno Therapeutics at 5.74%, RadNet at 4.93%, and KalVista Pharmaceuticals at 4.56%.
Total Holdings
37
Top 10 Percentage
48.41%
Asset Class
Equity
ETF Category
Health
Assets
68.04M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LIVN | LivaNova PLC | 6.71% |
| 2 | TVTX | Travere Therapeutics, Inc. | 6.22% |
| 3 | SLNO | Soleno Therapeutics, Inc. | 5.74% |
| 4 | RDNT | RadNet, Inc. | 4.93% |
| 5 | KALV | KalVista Pharmaceuticals, Inc. | 4.56% |
| 6 | TMDX | TransMedics Group, Inc. | 4.49% |
| 7 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.16% |
| 8 | MMSI | Merit Medical Systems, Inc. | 3.93% |
| 9 | BBIO | BridgeBio Pharma, Inc. | 3.87% |
| 10 | NKTR | Nektar Therapeutics | 3.79% |
| 11 | GH | Guardant Health, Inc. | 3.56% |
| 12 | WVE | Wave Life Sciences Ltd. | 3.49% |
| 13 | MIRM | Mirum Pharmaceuticals, Inc. | 3.40% |
| 14 | CORT | Corcept Therapeutics Incorporated | 3.12% |
| 15 | COLL | Collegium Pharmaceutical, Inc. | 3.01% |
| 16 | ATEC | Alphatec Holdings, Inc. | 2.94% |
| 17 | KRRO | Korro Bio, Inc. | 2.93% |
| 18 | COGT | Cogent Biosciences, Inc. | 2.92% |
| 19 | ETNB | 89bio, Inc. | 2.88% |
| 20 | RARE | Ultragenyx Pharmaceutical Inc. | 2.85% |
| 21 | INSM | Insmed Incorporated | 2.39% |
| 22 | AXSM | Axsome Therapeutics, Inc. | 2.06% |
| 23 | ACAD | ACADIA Pharmaceuticals Inc. | 1.84% |
| 24 | SVRA | Savara Inc. | 1.84% |
| 25 | ITGR | Integer Holdings Corporation | 1.73% |
As of Sep 9, 2025